Liver Cancer News and Research

RSS

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.

Researchers question exclusion of people with prior cancer history from clinical trials

A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern's Simmons Cancer Center have found.

22 Nov 2017

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population.

22 Nov 2017

Research findings offer prime drug targets to treat rare liver cancer that strikes young people

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults.

22 Nov 2017

Researchers find way to switch tumor cells between 2D and 3D morphology

Paving the way for testing experimental drugs in more realistic environments, scientists at the National Institute of Standards and Technology have discovered how to make tiny colonies of cells grow in useful new ways inside petri dishes.

17 Nov 2017

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs.

14 Nov 2017

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death.

8 Nov 2017

New program targets cancers affecting the liver and bile ducts

Cancers affecting the liver and bile ducts will be the target of a new program at Perlmutter Cancer Center at NYU Langone Health to provide multidisciplinary clinical care and rapidly bring important new research to the clinic.

7 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

Scientists make breakthrough by suppressing aflatoxin-producing fungus in groundnut

Scientists at the Donald Danforth Plant Science Center, in St. Louis, MO and their collaborators at the International Crops Research Institute for the Semi-Arid Tropics in Hyderabad, India, United States Department of Agriculture and Louisiana State University have made a significant research breakthrough by suppressing the aflatoxin-producing fungus in groundnut.

1 Nov 2017

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

30 Oct 2017

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

A new study presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases - found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

20 Oct 2017

Study examines risk of using liver organs from hepatitis C positive donors

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

20 Oct 2017

HCV screening or diagnosis could lower non‐prescribed opioid use

Research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

20 Oct 2017

Liver cancers linked to compound popular in herbal remedies

A latest study has shown that Aristolochic Acids (AA) – that are commonly used as a natural product found in some natural remedies, could be associated with liver cancers. Researchers from Singapore and Taiwan showed in their study that AA could be causing mutations in the genes that predispose an individual to liver cancers.

19 Oct 2017

USC discovery may one day lead to new therapies for liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate that continues to balloon.

12 Oct 2017

Study documents gene mutation as cause of cancer form in the liver

There is no effective treatment for the cancer form found in the liver called fibrolamellar hepatocellular carcinoma, which is mainly found among children and young people.

12 Oct 2017

Fundamental discovery may open potential for new types of cancer drugs

Many approved cancer therapies target a protein called epidermal growth factor receptor (EGFR) that regulates many crucial cellular processes and can speed the proliferation of tumor cells.

11 Oct 2017

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.

9 Oct 2017

Liver Cancer News and Research

Further Reading

Researchers question exclusion of people with prior cancer history from clinical trials

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

Research findings offer prime drug targets to treat rare liver cancer that strikes young people

Researchers find way to switch tumor cells between 2D and 3D morphology

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

New program targets cancers affecting the liver and bile ducts

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Fat hormone associated with NASH may be effective target for therapeutic intervention

Scientists make breakthrough by suppressing aflatoxin-producing fungus in groundnut

Canadian and Israeli researchers join forces for new research program

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

Study examines risk of using liver organs from hepatitis C positive donors

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

HCV screening or diagnosis could lower non‐prescribed opioid use

Liver cancers linked to compound popular in herbal remedies

USC discovery may one day lead to new therapies for liver cancer

Study documents gene mutation as cause of cancer form in the liver

Fundamental discovery may open potential for new types of cancer drugs

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News